Included patients n = 190 | Excluded patients n = 289 | |
---|---|---|
Sex | ||
Male | 70 (36.8) | 105 (36.3) |
Female | 120 (63.2) | 182 (63.0) |
Age, years | ||
18–29 | 40 (21.1) | 47 (16.3) |
30–39 | 41 (21.6) | 72 (24.9) |
40–49 | 36 (18.9) | 44 (15.2) |
50–59 | 29 (15.3) | 36 (12.5) |
60–69 | 18 (9.5) | 43 (14.9) |
>70 | 26 (13.7) | 46 (15.9) |
Ethnic group | ||
White | 118 (62.1) | 168 (58.1) |
Black/Black British | 37 (19.5) | 54 (18.7) |
Asian/Asian British | 5 (2.6) | 12 (4.2) |
Other | 26 (13.7) | 48 16.6) |
Highest qualification | ||
None | 49 (25.8) | 88 (30.4) |
GCSEs/A levels | 45 (23.7) | 65 (22.5) |
Degree or higher | 61 (32.1) | 82 (28.4) |
Other/unclear | 32 (16.8) | 42 (14.5) |
Agreed most important medicine decision | ||
New or repeat prescription | 146 (76.8) | n/a |
Change to a different medicine | 14 (7.4) | n/a |
Change of amount/frequency | 10 (5.3) | n/a |
Medicine discussed, not issued | 6 (3.2) | n/a |
Medicine stopped | 5 (2.6) | n/a |
Other decision | 9 (4.7) | n/a |
↵a Patient–GP pairs were included in the analyses if they agreed on the patient's main health problem, reported that a medicine decision had been made, and agreed about what this decision was. n/a = not applicable.